Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine (CCJM)
This case study describes an adult man with a history of diabetes and hypertension presenting with painful lesions on his arms and legs. The description covers the course of his workup for presumptive infectious dermatitis through differential diagnosis when the infectious disease workup revealed sterile lesions, to the final diagnosis of Sweet syndrome (acute febrile neutrophilic dermatosis).
Dermatology August 4th 2022
Physicians commonly encounter patients with facial pigmented macules. In this patient, the diagnosis was Carney complex.
Dermatology July 26th 2022
MDLinx
Anxiety disorders are among the most common of psychiatric disorders, with estimates suggesting a lifetime prevalence in the US of approximately 32%. But development of new and effective treatments for anxiety disorders has lagged behind new treatments for other conditions such as major depressive disorder, bipolar disorder, and schizophrenia. This article reviews current treatment and their effectiveness, and highlights the emerging new hopefuls.
Family Medicine/General Practice July 26th 2022
Medical Professionals Reference (MPR)
In its alert, the CDC warned doctors that these viruses circulate in the summer and fall and that they should be considered as a potential infection in an infant with fever, sepsis, or neurological symptoms.
Allergy & Immunology July 26th 2022
JAMA Network
In 2021, melatonin was the most frequently reported substance involved in pediatric substance ingestions, resulting in 4,000 hospitalizations, 287 ICU admissions, and 2 deaths in children under the age of 2. Melatonin supplements can have 500% more melatonin than indicated on the label and about 30% of OTC products tested had serotonin as well.
Emergency Medicine July 19th 2022
British Medical Journal (The BMJ)
A comprehensive review on the widespread uptake of vaping, including its origins and history, a timeline of discoveries, terminology, epidemiology, its use as a “harm reducer,” clinical presentations of vaping lung injuries (including an overview of the 2019 EVALI outbreak), the pathophysiology of vaping-induced lung injury, clinical aspects including outcomes, COVID-19 considerations, future directions, guidelines, and questions for future research.
Family Medicine/General Practice July 19th 2022